Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Advanced Enzyme Technologies Limited Capital/Financing Update 2025

Mar 27, 2025

62369_rns_2025-03-27_5aecf993-90ad-4e1e-86aa-c02f6c364469.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

March 27, 2025

BSE Limited National Stock Exchange of India Limited P. J. Towers, Exchange Plaza, Plot No. C/1, Dalal Street, G Block, Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E) Mumbai- 400 051 Scrip Code-540025 Trading Symbol-ADVENZYMES

Dear Sir,

Subject: Intimation for grant of stock Options under Advanced Enzyme Technologies Limited - Employees Stock Option Scheme 2022 (“the Scheme”) Ref: ISIN: INE837H01020

We wish to inform you that Nomination and Remuneration Committee of the Board of Directors of the Company vide Circular Resolution passed on March 27, 2025, has approved the grant of 5,12,500 stock Options under the Employees Stock Option Scheme 2022 (“the Scheme”).

In view of the aforesaid, enclosed is Annexure I indicating the details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 for the above mentioned ESOP Grant.

The aforesaid is also being uploaded on the website of the Company i.e. www.advancedenzymes.com

This is for your information and for public at large.

Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited

SANJAY Digitally signed by PRAKASH SANJAY PRAKASH BASANTA BASANTANI Date: 2025.03.27 NI 16:12:06 +05'30'

Sanjay Basantani Company Secretary and Head – Legal Encl.: As above

Annexure-1

Disclosure pursuant to SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024

For “AETL - Employees Stock Option Scheme 2022” [‘ Scheme’ ]

Sr.
No.

Particulars

Remarks
1. Brief details of Options
granted
5,12,500 Options granted by the Nomination & Remuneration
Committee (vide Circular Resolution passed on March 27,
2025)to the Employees as defined under the Scheme.
2. Whether the scheme is
in terms of SEBI (SBEB)
Regulations,2021
Yes
3. Total number of shares
covered by these options
Stock Options granted under the aforesaid Grant covers
5,12,500 Equity Shares. 1 Option shall be entitled for
conversion to only 1 Share of the Company, subject to the
terms of the Scheme.
4. Pricing formula As per the Scheme, the Exercise Price including method for
arriving at it shall be determined by the Committee at the
time of Grant, provided that the said Exercise Price shall not
be higher than the prevailing Market Price (defined below) of
the Shares discounted by minimum 33.33% (ceiling); as may
be determined by the Committee based on the criteria
specified in the Scheme, subject to the Applicable Law; and
the Exercise Price per Option shall not be less than the then
prevailing face value (₹2) of the Equity Shares of the
Company.
As regards the captioned grant of Options under Category II
and Category III, the pricing formula determined by the
Committee is as follows:
Category II: Employees who have been granted Options upto
5,000 - First 500 Options at₹2/- each and remaining Options
at the discount of 50% on the Market Price (as defined below)
Category III: Employees who have been granted Options
more than 5,000 - 500 Options at₹2/- each. The Exercise price
for 4,500 Options shall be at the discount of 50% on the
Market Price. For the remaining Options, the Exercise Price
shall at the discount of 33.33% on the Market Price.
Note: Exercise Price may be rounded-off as regards decimals,
if any, within the Exercise Formula specified above read with
clause 11 of the ESOP Scheme.
5. Options Vested Not Applicable
6. Time within which
option may be exercised
Exercise period shall not exceed 6 (six) months from relevant
Vesting date and the date after which the Options shall lapse,
unless the said period is extended by the Committee in
exceptional circumstances. The Options shall not Vest for a
period of one year from the date of Grant. Upon the expiry of
one year, the Vesting of Options shall take place over a
maximum term of fiveyears asper clause 14 of the Scheme.
7. Options exercised Not Applicable
8. Money realised by
exercise of Options
Not Applicable
9. The total number of
shares arising as a result
of exercise of option
Not Applicable
10. Options lapsed Not Applicable
11. Variation of terms of
options
Not Applicable
12. Brief details of
significant terms
With reference to the aforesaid Exercise Price/Scheme, the
term "Market Price" means the average of Closing Price of the
Equity Shares of the Company on the recognized Stock
Exchange for last 90 (ninety) Trading Days preceding the date
of Grant (which for the captioned case is March 27, 2025 –
Grant Date)
Explanation: If the Equity Shares of the Company are listed on
more than one recognized Stock Exchange, then the Closing
Price on the recognized Stock Exchange having higher trading
volume, in aggregate is recorded for the said last 90 (ninety)
Trading Days shall be considered for the purpose of
determining the Market Price (which for the captioned Grant
is NSE considering the trading volume for last 90 Trading
Days).
13. Subsequent changes or
cancellation or exercise
of such options
Not Applicable
14. Diluted earnings per
share pursuant to issue
of equity shares on
exercise of options.
Not Applicable